Production (Stage)
Coya Therapeutics, Inc.
COYA
$5.45
-$0.18-3.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.31% | -86.29% | 13.45% | 22.07% | 22.40% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -17.33% | -9.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.06% | 89.93% | -9.24% | -53.49% | -49.94% |
| Change in Net Operating Assets | -143.00% | 140.40% | -26.71% | 190.49% | 1,428.52% |
| Cash from Operations | -194.70% | 8.04% | 9.40% | 34.81% | 43.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 95.40% | 70.51% | 75.06% | -8.23% |
| Cash from Investing | 100.00% | 95.40% | 70.51% | 75.06% | -8.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.83% | -57.80% | 115.42% | 115.42% | 79.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -26.71% | -15.80% | 87.39% |
| Cash from Financing | -41.75% | -58.29% | 115.67% | 116.22% | 7.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.33% | -78.60% | 802.31% | 764.49% | 40.19% |